Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Association of clinical features with HLA in chronic pulmonary thromboembolism.

Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, Takahashi M, Shibata H, Yasunami M, Kuriyama T.

Eur Respir J. 2005 Jan;25(1):131-8.

2.

HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis.

Kominami S, Tanabe N, Ota M, Naruse TK, Katsuyama Y, Nakanishi N, Tomoike H, Sakuma M, Shirato K, Takahashi M, Shibata H, Yasunami M, Chen Z, Kasahara Y, Tatsumi K, Kuriyama T, Kimura A.

J Hum Genet. 2009 Feb;54(2):108-14. doi: 10.1038/jhg.2008.15. Epub 2009 Jan 23.

PMID:
19165231
3.
4.

Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan.

Horiki T, Inoko H, Moriuchi J, Ichikawa Y, Arimori S.

Autoimmunity. 1994;19(1):49-54.

PMID:
7749041
5.

Angiotensin-converting enzyme gene polymorphisms and prognosis in chronic thromboembolic pulmonary hypertension.

Tanabe N, Amano S, Tatsumi K, Kominami S, Igarashi N, Shimura R, Matsubara H, Kasahara Y, Takiguchi Y, Kuriyama T.

Circ J. 2006 Sep;70(9):1174-9.

6.

Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.

Wu XM, Wang C, Zhang KN, Lin AY, Kira J, Hu GZ, Qu XH, Xiong YQ, Cao WF, Gong LY.

Mult Scler. 2009 Dec;15(12):1422-30. doi: 10.1177/1352458509345905. Epub 2009 Nov 13.

PMID:
19965521
7.

Associations between six classical HLA loci and rheumatoid arthritis: a comprehensive analysis.

Mitsunaga S, Suzuki Y, Kuwana M, Sato S, Kaneko Y, Homma Y, Narita A, Kashiwase K, Okudaira Y, Inoue I, Kulski JK, Inoko H.

Tissue Antigens. 2012 Jul;80(1):16-25. doi: 10.1111/j.1399-0039.2012.01872.x. Epub 2012 Apr 4.

PMID:
22471586
8.

Gender differences in chronic thromboembolic pulmonary hypertension in Japan.

Shigeta A, Tanabe N, Shimizu H, Hoshino S, Maruoka M, Sakao S, Tada Y, Kasahara Y, Takiguchi Y, Tatsumi K, Masuda M, Kuriyama T.

Circ J. 2008 Dec;72(12):2069-74. Epub 2008 Oct 17.

9.

Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.

Wong CL, Szydlo R, Gibbs S, Laffan M.

Blood Coagul Fibrinolysis. 2010 Apr;21(3):201-6. doi: 10.1097/MBC.0b013e328331e664.

PMID:
20182352
10.

[Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].

Wu XM, Zhang KN, Wang CD, Xiong YQ, Liu Z, Qu XH, Xie XF.

Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2741-4. Chinese.

PMID:
18167262
11.

Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.

Lang IM, Simonneau G, Pepke-Zaba JW, Mayer E, Ambrož D, Blanco I, Torbicki A, Mellemkjaer S, Yaici A, Delcroix M.

Thromb Haemost. 2013 Jul;110(1):83-91. doi: 10.1160/TH13-02-0097. Epub 2013 May 16.

PMID:
23677493
12.

HLA-DQB1 and -DPB1 allele profile in HIV infected patients with and without pulmonary tuberculosis of south India.

Selvaraj P, Raghavan S, Swaminathan S, Alagarasu K, Narendran G, Narayanan PR.

Infect Genet Evol. 2008 Sep;8(5):664-71. doi: 10.1016/j.meegid.2008.06.005. Epub 2008 Jul 5.

PMID:
18652916
13.

Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors.

Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I, Tsukishima E, Sasaki H, Hamada T, Nishimura Y, Tashiro K, Kira J.

Tissue Antigens. 2000 Mar;55(3):199-205.

PMID:
10777094
14.

HLA-DPB1 DNA polymorphism in the Swiss population: linkage disequilibrium with other HLA loci and population genetic affinities.

Grundschober C, Sanchez-Mazas A, Excoffier L, Langaney A, Jeannet M, Tiercy JM.

Eur J Immunogenet. 1994 Jun;21(3):143-57.

PMID:
9098428
15.

Association of deep vein thrombosis type with clinical phenotype of chronic thromboembolic pulmonary hypertension.

Kantake M, Tanabe N, Sugiura T, Shigeta A, Yanagawa N, Jujo T, Kawata N, Amano H, Matsuura Y, Nishimura R, Sekine A, Sakao S, Kasahara Y, Tatsumi K.

Int J Cardiol. 2013 May 25;165(3):474-7. doi: 10.1016/j.ijcard.2011.08.851. Epub 2011 Sep 17.

PMID:
21930318
16.

Association between alopecia areata and HLA Class I and II in Turkey.

Aliagaoglu C, Pirim I, Atasoy M, Egerci N, Aktas A.

J Dermatol. 2005 Sep;32(9):711-4.

PMID:
16361713
17.

HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy.

Chinoy H, Payne D, Poulton KV, Fertig N, Betteridge Z, Gunawardena H, Davidson JE, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG; UK Adult Onset Myositis Immunogenetic Collaboration & UK Juvenile Dermatomyositis Research Group.

Rheumatology (Oxford). 2009 Oct;48(10):1213-7. doi: 10.1093/rheumatology/kep248. Epub 2009 Aug 18.

PMID:
19690132
18.

HLA-DR/DQ/DP interactions in rheumatoid arthritis.

Seidl C, Koch U, Brünnler G, Buhleier T, Frank R, Möller B, Markert E, Koller-Wagner G, Seifried E, Kaltwasser JP.

Eur J Immunogenet. 1997 Oct;24(5):365-76.

PMID:
9442804
19.

HLA markers for susceptibility and expression in scleroderma.

Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P.

J Rheumatol. 2005 Aug;32(8):1481-7.

PMID:
16078323
20.

Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C.

Higashi Y, Kamikawaji N, Suko H, Ando M.

J Gastroenterol Hepatol. 1996 Mar;11(3):241-6.

PMID:
8742920

Supplemental Content

Support Center